Mohamed Slaoui

724 total citations
11 papers, 466 citations indexed

About

Mohamed Slaoui is a scholar working on Small Animals, Immunology and Molecular Biology. According to data from OpenAlex, Mohamed Slaoui has authored 11 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Small Animals, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Mohamed Slaoui's work include Animal testing and alternatives (5 papers), Immunotoxicology and immune responses (4 papers) and Carcinogens and Genotoxicity Assessment (2 papers). Mohamed Slaoui is often cited by papers focused on Animal testing and alternatives (5 papers), Immunotoxicology and immune responses (4 papers) and Carcinogens and Genotoxicity Assessment (2 papers). Mohamed Slaoui collaborates with scholars based in France, United States and Germany. Mohamed Slaoui's co-authors include Laurence Fiette, Anne-Laure Bauchet, Magali Guffroy, Régis Masson, Eric van Esch, Eric Boitier, Yaligara Veeranagouda, Yi Yang, Thomas Joos and Bo Li and has published in prestigious journals such as Toxicology and Applied Pharmacology, Toxicological Sciences and Biomedicine & Pharmacotherapy.

In The Last Decade

Mohamed Slaoui

11 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamed Slaoui France 6 91 58 42 42 35 11 466
Frank Gohs United States 6 63 0.7× 30 0.5× 25 0.6× 33 0.8× 21 0.6× 12 367
Yingying Liu China 16 217 2.4× 48 0.8× 31 0.7× 77 1.8× 45 1.3× 62 782
Priscilla Masamba South Africa 10 200 2.2× 48 0.8× 16 0.4× 30 0.7× 25 0.7× 22 449
David J. Honor Canada 9 59 0.6× 51 0.9× 55 1.3× 27 0.6× 26 0.7× 14 352
Katherine A. Stitzel United States 11 96 1.1× 60 1.0× 61 1.5× 98 2.3× 32 0.9× 28 550
Naohisa Tsutsui Japan 11 196 2.2× 83 1.4× 97 2.3× 45 1.1× 74 2.1× 20 531
Mohsen Masoodi Iran 16 155 1.7× 49 0.8× 42 1.0× 28 0.7× 37 1.1× 58 669
Hongqing Zhu China 14 114 1.3× 58 1.0× 19 0.5× 79 1.9× 18 0.5× 37 484
Richard Allan United Kingdom 14 105 1.2× 72 1.2× 21 0.5× 12 0.3× 54 1.5× 39 661
Stefan F.C. Vaessen Netherlands 13 154 1.7× 24 0.4× 34 0.8× 32 0.8× 52 1.5× 24 557

Countries citing papers authored by Mohamed Slaoui

Since Specialization
Citations

This map shows the geographic impact of Mohamed Slaoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Slaoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Slaoui more than expected).

Fields of papers citing papers by Mohamed Slaoui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamed Slaoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Slaoui. The network helps show where Mohamed Slaoui may publish in the future.

Co-authorship network of co-authors of Mohamed Slaoui

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamed Slaoui. A scholar is included among the top collaborators of Mohamed Slaoui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamed Slaoui. Mohamed Slaoui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Balayssac, David, Jérôme Busserolles, Damien Richard, et al.. (2023). Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project. Biomedicine & Pharmacotherapy. 167. 115535–115535. 5 indexed citations
2.
Fiette, Laurence, Mohamed Slaoui, & Anne-Laure Bauchet. (2017). Procedures of Necropsy and Tissue Sampling. Methods in molecular biology. 1641. 71–100. 2 indexed citations
3.
Slaoui, Mohamed, Anne-Laure Bauchet, & Laurence Fiette. (2017). Tissue Sampling and Processing for Histopathology Evaluation. Methods in molecular biology. 1641. 101–114. 63 indexed citations
4.
Gautier, Jean‐Charles, Xiaobing Zhou, Yi Yang, et al.. (2016). Evaluation of novel biomarkers of nephrotoxicity in Cynomolgus monkeys treated with gentamicin. Toxicology and Applied Pharmacology. 303. 1–10. 31 indexed citations
5.
Krupp, Eckart, et al.. (2016). Use of novel kidney safety biomarkers RPA-1 and clusterin as a selection tool for GPCR-agonists. Toxicology Letters. 258. S85–S85. 1 indexed citations
6.
Guillon, Jean‐Michel, et al.. (2012). Integration into preclinical toxicity studies of functional endpoints captured with telemetry: To implant or not?. Journal of Pharmacological and Toxicological Methods. 66(2). 172–173. 1 indexed citations
7.
Bauchet, Anne-Laure, Régis Masson, Magali Guffroy, & Mohamed Slaoui. (2011). Immunohistochemical Identification of Kidney Nephron Segments in the Dog, Rat, Mouse, and Cynomolgus Monkey. Toxicologic Pathology. 39(7). 1115–1128. 25 indexed citations
8.
Slaoui, Mohamed & Laurence Fiette. (2010). Histopathology Procedures: From Tissue Sampling to Histopathological Evaluation. Methods in molecular biology. 691. 69–82. 300 indexed citations
9.
Fiette, Laurence & Mohamed Slaoui. (2010). Necropsy and Sampling Procedures in Rodents. Methods in molecular biology. 691. 39–67. 26 indexed citations
10.
Michel, Cécile, Chantal Desdouets, Mohamed Slaoui, et al.. (2007). Diethylnitrosamine Initiation Does Not Alter Clofibric Acid–Induced Hepatocarcinogenesis in the Rat. Toxicological Sciences. 99(1). 58–69. 4 indexed citations
11.
Slaoui, Mohamed, et al.. (1998). Inflammatory Lesions in the Lungs of Wistar Rats. Toxicologic Pathology. 26(5). 712–713. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026